Showing results (21-30 of 136) with videos related to
Sort By:
Pageof 14
BMC Bioinformatics|November 25, 2017
HashClone: a new tool to quantify the minimal residual disease in B-cell lymphoma from deep sequencing dataMarco Beccuti, Elisa Genuardi, Greta Romano, et al.Dentistry Journal|March 23, 2018
Osteonecrosis of the Jaws (ONJ) after Bisphosphonate Treatment in Patients with Multiple Myeloma: Decreasing ONJ Incidence after Adoption of Preventive MeasuresGioacchino Catania, Federico Monaco, Giulia Limberti, et al.Medical Oncology (Northwood, London, England)|October 5, 2006
High-risk fludarabine-pretreated B-cell chronic lymphocytic leukemia's high response rate following sequential DHAP and alemtuzumab administration though in absence of molecular remissionIgnazio Majolino, Marco Ladetto, Anna Locasciulli, et al.European Journal of Haematology|January 15, 2026
VULVO-Vaginal Chronic Graft-Versus-Host Disease Assessment: A Single-Center Prospective Observational StudyFrancesca Palmisano, Chiara Cannici, Rita Tavarozzi, et al.Radiology Case Reports|September 10, 2021
Spontaneous splenic rupture during induction therapy in acute myeloid leukemia: An unusual caseRita Tavarozzi, Tiziana Borra, Gioacchino Catania, et al.Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|June 9, 2016
A Single-Center Pilot Prospective Study of Topical Application of Platelet-Derived Eye Drops for Patients with Ocular Chronic Graft-versus-Host DiseaseFrancesco Zallio, Laura Mazzucco, Federico Monaco, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 16, 2004
Long-term follow-up of indolent lymphoma patients treated with high-dose sequential chemotherapy and autografting: evidence that durable molecular and clinical remission frequently can be attained only in follicular subtypesPaolo Corradini, Marco Ladetto, Francesco Zallio, et al.Cancers|January 20, 2021
Allogeneic Stem Cell Transplantation in Mantle Cell Lymphoma in the Era of New Drugs and CAR-T Cell TherapyMiriam Marangon, Carlo Visco, Anna Maria Barbui, et al.British Journal of Haematology|May 18, 2021
Application of the Euro Clonality next-generation sequencing-based marker screening approach to detect immunoglobulin heavy chain rearrangements in mantle cell lymphoma patients: first data from the Fondazione Italiana Linfomi MCL0208 trialElisa Genuardi, Greta Romano, Marco Beccuti, et al.Cytotherapy|September 10, 2025
Overcoming barriers to referral for CAR T-cell therapy in patients with non-Hodgkin aggressive B-cell lymphomas: A Delphi consensusStefano Luminari, Annalisa Chiappella, Alice Di Rocco, et al.Pageof 14